Search > Results
You searched for: EV220318 (EV-TRACK ID)
Showing 1 - 4 of 4
Showing 1 - 4 of 4
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV220318 | 1/4 | Mus musculus | CAD5 | (d)(U)C | Jakub Soukup | 2023 | 67% | |
Study summaryFull title
All authors
Jakub Soukup, Tibor Moško, Sami Kereïche, Karel Holada
Journal
Biochem Pharmacol
Abstract
Prions are responsible for a number of lethal neurodegenerative and transmissible diseases in humans (show more...)
EV-METRIC
67% (94th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Prion infected cell culture
Focus vesicles
large extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: Alix/ CD9/ CD63/ HSP70/ TSG101/ Integrin-beta1/ CD81/ PrP
non-EV: Calnexin Proteomics
no
Show all info
Study aim
Mechanism of uptake/transfer/Identification of content (omics approaches)
Sample
Species
Mus musculus
Sample Type
Cell culture supernatant
EV-producing cells
CAD5
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g Between 10,000 g and 50,000 g Pelleting performed
Yes
Pelleting: rotor type
SW 28
Pelleting: speed (g)
19827
Wash: volume per pellet (ml)
13.5
Wash: time (min)
70
Wash: Rotor Type
SW 40 Ti
Wash: speed (g)
19556.1
Characterization: Protein analysis
Protein Concentration Method
microBCA
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
Alix/ CD9/ CD63/ HSP70/ TSG101/ Integrin-beta1/ PrP
Not detected EV-associated proteins
CD81
Not detected contaminants
Calnexin
Characterization: Lipid analysis
No
Characterization: Particle analysis
EM
EM-type
Transmission-EM/ Cryo-EM
Image type
Close-up, Wide-field
Extra information
We have isolated and analysed Large and Small extracellular vesicles from the same conditioned medium aiming to separate them and use them for infection. Large EVs supposed to be above 70 nm in size and enriched in Beta 1 integrin while Small EVs are 30-150 nm and depleted in Beta 1 integrin. Secondary cell culture served as control.
|
||||||||
EV220318 | 2/4 | Mus musculus | CAD5 |
(d)(U)C DC |
Jakub Soukup | 2023 | 67% | |
Study summaryFull title
All authors
Jakub Soukup, Tibor Moško, Sami Kereïche, Karel Holada
Journal
Biochem Pharmacol
Abstract
Prions are responsible for a number of lethal neurodegenerative and transmissible diseases in humans (show more...)
EV-METRIC
67% (94th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Prion infected cell culture
Focus vesicles
small extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Density cushion Protein markers
EV: Alix/ CD9/ CD63/ HSP70/ TSG101/ CD81/ PrP
non-EV: Calnexin/ Integrin-beta1 Proteomics
no
Show all info
Study aim
Mechanism of uptake/transfer/Identification of content (omics approaches)
Sample
Species
Mus musculus
Sample Type
Cell culture supernatant
EV-producing cells
CAD5
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: rotor type
SW 28
Pelleting: speed (g)
112398.1
Wash: volume per pellet (ml)
13.5
Wash: time (min)
70
Wash: Rotor Type
SW 40 Ti
Wash: speed (g)
110862.3
Density cushion
Density medium
Sucrose
Sample volume
11
Cushion volume
2.5
Density of the cushion
40%
Centrifugation time
70
Centrifugation speed
110862.3
Characterization: Protein analysis
Protein Concentration Method
microBCA
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
Alix/ CD9/ CD63/ HSP70/ TSG101/ PrP
Not detected EV-associated proteins
CD81
Detected contaminants
Integrin-beta1
Not detected contaminants
Calnexin
Characterization: Lipid analysis
No
Characterization: Particle analysis
EM
EM-type
Transmission-EM/ Cryo-EM
Image type
Close-up, Wide-field
Report size (nm)
79
|
||||||||
EV220318 | 3/4 | Mus musculus | PK1 | (d)(U)C | Jakub Soukup | 2023 | 56% | |
Study summaryFull title
All authors
Jakub Soukup, Tibor Moško, Sami Kereïche, Karel Holada
Journal
Biochem Pharmacol
Abstract
Prions are responsible for a number of lethal neurodegenerative and transmissible diseases in humans (show more...)
EV-METRIC
56% (90th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Prion infected cell culture
Focus vesicles
large extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: Alix/ CD9/ CD63/ HSP70/ TSG101/ Integrin-beta1/ CD81/ PrP
non-EV: Calnexin Proteomics
no
Show all info
Study aim
Mechanism of uptake/transfer/Identification of content (omics approaches)
Sample
Species
Mus musculus
Sample Type
Cell culture supernatant
EV-producing cells
PK1
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g Between 10,000 g and 50,000 g Pelleting performed
Yes
Pelleting: rotor type
SW 28
Pelleting: speed (g)
19827
Wash: volume per pellet (ml)
13.5
Wash: time (min)
70
Wash: Rotor Type
SW 40 Ti
Wash: speed (g)
19556.1
Characterization: Protein analysis
Protein Concentration Method
microBCA
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
Alix/ CD9/ CD63/ HSP70/ TSG101/ Integrin-beta1/ PrP
Not detected EV-associated proteins
CD81
Not detected contaminants
Calnexin
Characterization: Lipid analysis
No
Characterization: Particle analysis
EM
EM-type
Transmission-EM
Image type
Wide-field
|
||||||||
EV220318 | 4/4 | Mus musculus | PK1 |
(d)(U)C DC |
Jakub Soukup | 2023 | 56% | |
Study summaryFull title
All authors
Jakub Soukup, Tibor Moško, Sami Kereïche, Karel Holada
Journal
Biochem Pharmacol
Abstract
Prions are responsible for a number of lethal neurodegenerative and transmissible diseases in humans (show more...)
EV-METRIC
56% (90th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Prion infected cell culture
Focus vesicles
small extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Density cushion Protein markers
EV: Alix/ CD9/ CD63/ HSP70/ TSG101/ CD81/ PrP
non-EV: Calnexin/ Integrin-beta1 Proteomics
no
Show all info
Study aim
Mechanism of uptake/transfer/Identification of content (omics approaches)
Sample
Species
Mus musculus
Sample Type
Cell culture supernatant
EV-producing cells
PK1
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: rotor type
SW 28
Pelleting: speed (g)
112398.1
Wash: volume per pellet (ml)
13.5
Wash: time (min)
70
Wash: Rotor Type
SW 40 Ti
Wash: speed (g)
110862.3
Density cushion
Density medium
Sucrose
Sample volume
11
Cushion volume
2.5
Density of the cushion
40%
Centrifugation time
70
Centrifugation speed
110862.3
Characterization: Protein analysis
Protein Concentration Method
microBCA
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
Alix/ CD9/ CD63/ HSP70/ TSG101/ PrP
Not detected EV-associated proteins
CD81
Detected contaminants
Integrin-beta1
Not detected contaminants
Calnexin
Characterization: Lipid analysis
No
Characterization: Particle analysis
EM
EM-type
Transmission-EM
Image type
Wide-field
|
||||||||
1 - 4 of 4 |
EV-TRACK ID | EV220318 | |||
---|---|---|---|---|
species | Mus musculus | |||
sample type | Cell culture | |||
cell type | CAD5 | CAD5 | PK1 | PK1 |
condition | Prion infected cell culture | Prion infected cell culture | Prion infected cell culture | Prion infected cell culture |
separation protocol | dUC | dUC/ DC | dUC | dUC/ DC |
vesicle related term | large EV | small EV | large EV | small EV |
Exp. nr. | 1 | 2 | 3 | 4 |
EV-METRIC % | 67 | 67 | 56 | 56 |